- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medical Resources buys three centers
Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition
Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition brings to 82 the number of centers operated by the company.
In other news, the company last month raised $26 million through an issue of senior notes to a group of insurance companies led by John Hancock Mutual Life Insurance. The Hackensack, NJ, company said it would use proceeds from the issue to fund acquisitions and for general corporate purposes. The placement brings the total amount that Medical Resources has raised this year through investment-grade senior note issues to $78 million.
In other Medical Resources news, the company acquired a controlling interest in a multimodality imaging center in midtown Manhattan. Medical Resources paid $1 million for the stake in the center, which is located within a state-of-the art medical suite to be opened by a private physician group this fall. The center is also the company's first joint venture with a physician practice management company.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
